Q4 2023 · 13F-HR
Column Group LLCholdings as filed
Filed 2024-02-09 · accession 0000950123-24-001345
$151.4M
Reported value
6
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 75382E109 | — | RAPT Therapeutics Inc | $66.6M | 44.0% | 2,680,621 | Common | SOLE |
| 68622P109 | ORIC | ORIC Pharmaceuticals Inc. | $32.8M | 21.7% | 3,568,181 | Common | SOLE |
| 87990A106 | TNYA | Tenaya Therapeutics, Inc. | $30.5M | 20.1% | 9,400,290 | Common | SOLE |
| 62921N105 | NGMUSD | NGM Biopharmaceuticals Inc | $15.6M | 10.3% | 18,136,735 | Common | SOLE |
| 86889P109 | — | Surrozen, Inc. | $5.9M | 3.90% | 627,651 | Common | SOLE |
| 76155X100 | RVMD | Revolution Medicines Inc | $1,319 | 0.00% | 46 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.